Drug Shortage Report for APO-LITHIUM CARBONATE
Report ID | 225802 |
Drug Identification Number | 02242837 |
Brand name | APO-LITHIUM CARBONATE |
Common or Proper name | LITHIUM CARBONATE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | LITHIUM CARBONATE |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | N05AN |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-04-16 |
Estimated end date | 2024-05-10 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-04-19 | French | Compare |
v1 | 2024-04-19 | English | Compare |
Showing 1 to 2 of 2